Neudle.com: sinemet

Neurology Specific Literature Search

Differential
(Click to cross reference)

abdominal protrusion

advances in neurology

adverse drug reaction

affective disorders

akinesia of eyelid function

alcohol, neurologic complications with

alien hand syndrome

alpha methyldopa hydrazine

alpha-synuclein

alternative medicine

Alzheimer's disease

amphetamines, dyskinesia associated with

anemia, iron deficiency

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

apraxia of eyelid opening

apraxia, constructional

aqueduct of Sylvius, stenosis

arm swing, reduced

arrhythmia, cardiac

arterial dissection, aorta, cerebral symptoms with

aspartate aminotransferase

attention deficit disorder with hyperactivity

auditory and vestibular pathways

autonomic cardiovascular reflexes

autonomic dysfunction

autonomic dysfunction, evaluation of

autonomic nervous system

ballismus, bilateral

basal ganglia, lesion, bilateral

behavioral disorder

Binswanger disease

biopterin deficiency

bladder dysfunction

blinking, reduced

botulinum toxin

brain transplantation

brainstem, lesion of

Brueghel's syndrome

burning paresthesia

burst suppression pattern, electroencephalogram

CAT scan, abnormal

CAT scan, emission

CAT scan, emission, abnormal

catechol-o-methyltransferase inhibitor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction, subcortical

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

chromosomal abnormality

cigarette smoking

Clinical Pathologic Conference(C.P.C.)

cogwheel rigidty

contractures, joint

contrast sensitivity

controversies in neurology

Coombs test, positive

cortical-basal ganglionic degeneration

cost effectiveness

crying, pathologic

cyst, arachnoid, infant

dantrolene sodium

degenerative diseases of CNS

delay in diagnosis

dementia, subcortical

dementia, treatment of

developmental milestones, loss of

dexterity, impaired

diabetes mellitus

differential diagnosis

disability rating scale, neurological

disability, neurological

diurnal variation

dopa responsive dystonia

dopamine agonist

dopamine receptor

dopamine receptor, D2

drug induced neurologic disorders

drug interactions

drug withdrawal

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, children

dystonia, etiology of

dystonia, evaluation of

dystonia, focal

dystonia, painful

dystonia, prevalence of

dystonia, symptomatic

dystonia, treatment of

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electroencephalogram, triphasic delta waves

electron microscopy

encephalitis, viral

encephalopathy, progressive

enzyme inhibition

epidemiology of neurology

extrapyramidal movement disorder, progressive

eye movement, disorders of

fine motor function, impaired

fludrocortisone

gait, festinating

gamma amino butyric acid

gastrointestinal bleeding

gaze palsy, supranuclear

gaze palsy, vertical

genetic counselling

genetic neurologic disorders

genetic screening

genetic testing

Gilles de la Tourette syndrome

hallucination, visual

head injury, brain stem lesion after

head injury, prognosis in

head injury, severe

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

homovanillic acid

Huntington's chorea

Huntington's chorea, presymptomatic detection of

hydroxyindole acetic acid 5(5HIAA)

hypometric saccades

iatrogenic neurologic disorders

ideomotor apraxia

imbalance, postural

intellectual deficit

intranasal medication

Isaacs syndrome

jaw jerk, abnormal

judgement, impaired

kinesia paradoxica

laughing, pathologic

L-dopa methyl ester

L-dopa, absorption

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, intravenous

L-dopa, plasma concentration

L-dopa, potentiators of

leg spasms, painful

leukoencephalopathy

Lewy body disease, diffuse

livedo reticularis

liver function enzymes

locus ceruleus, lesion of

manganese intoxication

manic-depressive

marche a petits pas

melanoma, malignant

memory, defect of recent

memory, impairment of

mental status, abnormal

microangiopathy, brain

midbrain, atrophy

midbrain, lesion of

migraine, treatment of

mitochondrial disease

molecular genetics

monoamine oxidase inhibitors

movement disorder

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

MRI, functional

multiple sclerosis

multiple sclerosis, diet in

multiple sclerosis, treatment of

multiple system atrophy

muscle atrophy, static

muscle stiffness

muscle weakness

myasthenic syndrome

myasthenic syndrome, treatment of

myoclonic jerks

myoclonus, sleep

nausea and vomiting

neuroendocrinology

neuroleptic malignant syndrome

neuroleptic sensitivity

neuroleptic, atypical

neurologic disease, diagnoses of

neurologic signs

neuronal degeneration

neuroophthalmology

neuropathology, brain

neuropathy, peripheral

neuroprotective agents

neurotransmitter

nigrostriatal pathway

obsessive-compulsive disorder

occupational neurologic disorders

ocular myopathy

ocular myopathy, differential diagnosis

old age, neurology of

ophthalmoplegia

oral contraceptives

oral contraceptives, choreiform movements with

orthostatic hypotension

orthostatic hypotension, idiopathic

orthostatic hypotension, treatment of

Othello syndrome

palliative care

parasympathetic nervous system

Parkinson disease

Parkinson disease, akinetic form

Parkinson disease, arteriosclerotic

Parkinson disease, axial symptoms

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, diet restricted in protein

Parkinson disease, differential diagnosis of

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, heterogeneity of

Parkinson disease, juvenile

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, mode of onset

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism multiple-system atrophy

Parkinsonism plus syndrome

Parkinsonism syndrome

pathologic gambling

patient information and support

penguin silhouette sign

periodic limb movements

periodic movements during sleep

persistent vegetative state

personality change

phenothiazine, dyskinesia associated with

phenylketonuria

postural abnormality

practice guidelines

pregnancy, neurologic complications in

pretectal syndrome

prevention of neurologic disorders

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

pseudobulbar palsy

psychiatric disorder

psychiatric problems in neurologic disorders

psychological testing, neurologic problems

psychomotor retardation

psychotic behavior

pure autonomic failure

pyridoxine deficiency

pyruvate-kinase deficiency anemia

reserpine and reserpine like drugs

respiratory dyskinesias

restless leg syndrome

reversible neurologic disorder

rigidity, axial

Riley-Day syndrome

ropinirole, prolonged release

saccadic eye movements, abnormal

seizure, pyridoxine dependent

selective serotonin reuptake inhibitors

sequencing difficulty

serum alanine aminotransferase

shunt procedure, ventricular-complications of

Shy-Drager syndrome

single photon emission computed tomography

sleep pathology and physiology

small vessel disease

speech disorder

speech disorder, childhood

spinocerebellar ataxia

spinocerebellar ataxia type 1

spinocerebellar ataxia type 2

spinocerebellar ataxia type 3/Machado Joseph disease

status epilepticus

stem cell transplantation

stereotyped behavior

stereotyped behavior, drug induced

steroid therapy, CNS treatment and complications with

stimulation, deep brain

subcortical U fibers

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

sweating, abnormality of

sympathetic nervous system

sympathomimetic drugs

syphilis, neurologic complications with

tardive dyskinesia

tetrahydrobiopterin

thrombophlebitis

tonic foot response

toxins, nervous system

treatment of neurologic disorder

tremor, postural

tremor, resting

tremor, thalamic stimulation for suppression of

tremor, treatment of

tricyclic antidepressant

trigeminal neuralgia

trinucleotide repeats

tyrosine hydroxylase deficiency

upgaze, paralysis of

urinary incontinence

varicella zoster virus

varicella zoster virus, encephalitis

vasospasm, cerebral

vertigo, cervical

vertigo, treatment of

vision, blurred

visual impairment

visual symptoms

visuospatial disturbance

vitamin deficiency

vitamin, multiple

walking, difficulty with

white matter disease

white matter disease, subcortical

Showing articles 50 to 100 of 231 << Previous Next >>

Spinocerebellar Ataxia Type 2 Presenting as Familial Levodopa-Responsive Parkinsonism
Ann Neurol 50:812-815, Shan,D.,et al, 2001

Axial Parkinsonian Symptoms Can Be Improved: The Role of Levodopa and Bilateral Subthalamic Stimulation
JNNP 68:595-600, Bejjani,B.P.,et al, 2000

Quetiapine for L-Dopa-Induced Psychosis in PD
Neurol 54:1538, Weiner,W.J.,et al, 2000

A Five-Year Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease who were Treated with Ropinirole or Levodopa
NEJM 342:1484-1491, Rascol,O.,et al, 2000

The Catechol-O-Methyltransferase (COMT) Inhibitor Entacapone Enhances the Pharmacokinetic and Clinical Response to Sinemet CR in Parkinson's Disease
JNNP 68:589-594, Piccinni,P.,et al, 2000

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA 284:1931-1938,1971, Parkinson Study Group, 2000

A Controlled Study of Additional sr-L-dopa in L-dopa-responsive Restless Legs Syndrome with Late-Night Symptoms
Neurol 52:285-290, Collado-Seidel,V.,et al, 1999

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999

Immediate-Release and Controlled-Release Carbidopa/Levodopa in PD, A 5-Year Randomized Multicenter Study
Neurol 53:1012-1019, Koller,W.C.,et al, 1999

Long-Term Follow-Up of Levodopa Responsiveness in Generalized Dystonia
Arch Neurol 55:1320-1323, Dewey,R.B.,et al, 1998

Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998

Dopa-Responsive Dystonia, Some Pieces of the Puzzle are Still Missing
Neurol 50:853-855, Nygaard,T.G.&Wooten,G.F., 1998

Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998

Investig of PDRG of UK into Excess Mortality Seen/Comb Levodopa & Selegiline Trmt in Pts with Early, Mild Parkinson's Dis
BMJ 316:1191-1196, Ben-Shlomo,Y.,et al, 1998

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Random, Placebo-Contr Study of Tolcapone in Pts with Fluctuating Parkinson Dis Trtd With Levodopa-Carbidopa
Arch Neurol 55:1089-1095, Adler,C.H.,et al, 1998

Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease
Lancet 351:1221-1222, Nutt,J.G., 1998

Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients
Neurol 51:811-814, Goetz,C.G.,et al, 1998

Subcotical Arteriosclerotic Encephalopathy (Binswangers Disease)
, Ghika,J. &Bogousslavsky, J., 1998

Cabergoline Treatment of Early Parkinson's Disease:First Yr of Trtm Comparison of Cabergoline & Levodopa
Neurol 48:363-368, Rinne,U.K.,et al, 1997

Low-Dose Clozapine Improves Dyskinesias in Parkinson's Disease
Neurol 48:658-662, Durif,F.,et al, 1997

Managing the Late Complications of Parkinson's Disease
Neurol 49:549-557, Waters,C.H., 1997

COMT Inhibition with Tolcapone Reduces the"Wearing Off"Phenomenon & Levodopa Requirements in Fluctuating Parkinsonisn Pts
JNNP 63:421-428, Baas,H.,et al, 1997

Sympathetic Cardioneuropathy in Dysautonomias
NEJM 336:696-702, 7211997., Goldstein,D.S.,et al, 1997

Restless Legs Syndrome:Clinicoetiologic Correlates
Neurol 47:1435-1441, Ondo,W.&Jankovic,J., 1996

Nonmotor Fluctuations in Patients with Parkinson's Disease
Neurol 47:1180-1183, Hillen,M.E.&Sage,J.I., 1996

Liquid Levodopa/Carbidopa Produces Significant Improvement in Motor Function without Dyskinesia Exacerbation
Neurol 47:1493-1495, Pappert,E.J.,et al, 1996

Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995

Comparative Study of Selegiline Plus L-Dopa-Carbidopa VS L-Dopa-Carbidopa Alone in Trtm of Parkinson's Disease
Ann Neurol 37:95-98, Brannan,T.&Yahr,M.D., 1995

Low-Dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease
Neurol 45:432-434, Rabey,J.M.,et al, 1995

Neuroleptic Drug Exposure and Treatment of Parkinsonism in the Elderly:A Case-Control Study
Am J Med 99:48-54, Avorn,J.,et al, 1995

A Greek-American Kindred with Autosomal Dominant, Levodopa-Responsive Parkinsonism and Anticipation
Ann Neurol 38:373-378, 3551995., Markopoulou,K.,et al, 1995

Multiple System Atrophy presenting as Parkinsonism:Clinical Features and Diagnostic Criteria
JNNP 59:144-151, Albanese,A.,et al, 1995

Occurrence of Different Cancers in Patients with Parkinson's Disease
BMJ 310:1500-1501, Moller,H.,et al, 1995

Increased Incidence of Levodopa Therapy Following Metoclopramide Use
JAMA 274:1780-1782, Avorn,J.,et al, 1995

Dopa-Responsive parkinsonism Phenotype of Machado-Jospeh Disease:Confirmation of 14q CAG Expansion
Ann Neurol 48:684-687, Tuite,P.J.,et al, 1995

Comparison of Therapeutic Effects & Mortality Data of Levodopa & Levodopa with Selegiline in Pts with Early, Mild Parkinson's
BMJ 311:1602-1607, 15831995., Lee,A.J.,et al, 1995

The Effect of Deprenyl and Levodopa on the Progression of Parkinson's Disease
Ann Neurol 38:771-777, Olanow,C.W.,et al, 1995

Reverse Shapiro's Syndrome:Hirayama
K. , et al, Arch Neurol 51:494-49694., , 1994

Levodopa Failure in Chronic Manganism
Neurol 44:1600-1602, 15831994., Lu,C-S.,et al, 1994

Dopa-Responsive Dystonia:Pathological and Biochemical Observations in a Case
Ann Neurol 35:396-402, 3811994., Rajput,A.H.,et al, 1994

A Multicenter Double-Blind Placebo-Controlled Trial of Pergolide as an Adjunct to Sinemet in Parkinson's Disease
Movement Disorders, 9:40-471994., Olanow,C.W.,et al, 1994

Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994

Parkinsonism Induced by Solvent Abuse
Ann NEurol 35:616-618, Uitti,R.J.,et al, 1994

Dopaminergic Treatment of Restless Legs and Rebound Phenomenon
Neurol 43:455, Guilleminault,C.,et al, 1993

Comparisons of Therapeutic Effects of Levodopa
Levodopa & Selegiline, & Bromocriptine in Pts with Early, Mild Parkinson's, Parkinson's Res Grp in U, , BMJ 372,1993., 1993

Levodopa, Melanoma, and Parkinson's Disease
Neurol 43:674-677, Weiner,W.J.,et al, 1993

Clinical Experience with Controlled-Release Carbidopa/Levodopa in Parkinson's Disease
Neurol 43:677-681, Pahwa,R.,et al, 1993

Levodopa Improves Spatial Contrast Sensitivity in Parkinson's Disease
Arch Neurol 50:721-724, Hutton,J.T.,et al, 1993

The Spectrum of Levodopa-Related Fluctuations in Parkinson's Disease
Neurol 43:1459-1464, Riley,D.E.&Lang,A.E., 1993

Showing articles 50 to 100 of 231 << Previous Next >>